LobbyingAmerican Academy of Physical Medicine and Rehabilitation lobbying by quarter
American Academy of Physical Medicine and Rehabilitation's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q2 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
American Academy of Physical Medicine and Rehabilitation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2022 | $10K | 1 |
| Q3 2022 | $10K | 1 |
| Q4 2022 | $10K | 1 |
| Q1 2023 | $0 | 0 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$110K · 14 reports
- Medical research and clinical labs$110K · 14 reports
- Medicare and Medicaid$110K · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Health & Human Services, Dept of (HHS)14 reports
- HOUSE OF REPRESENTATIVES14 reports
- Natl Institutes of Health (NIH)14 reports
- SENATE14 reports
- Food & Drug Administration (FDA)6 reports
- Veterans Affairs, Dept of (VA)4 reports
- Centers For Disease Control & Prevention (CDC)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Academy of Physical Medicine and Rehabilitation | $340K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $30K |
| 04/20for Q1 | In-house | $30K |
| 01/20for Q4 2025 | In-house | $30K |
| 25/10/20for Q3 2025 | In-house | $30K |
| 25/07/21for Q2 2025 | In-house | $30K |
| 25/04/21for Q1 2025 | In-house | $20K |
| 25/01/21for Q4 2024 | In-house | $20K |
| 24/10/21for Q3 2024 | In-house | $20K |
| 24/07/22for Q2 2024 | In-house | $40K |
| 24/07/11for Q1 2024 | In-house | $20K |
| 24/07/11for Q4 2023 | In-house | $20K |
| 23/10/20for Q3 2023 | In-house | $20K |
| 23/07/27for Q4 2022 | In-house | $10K |
| 23/02/17for Q3 2022 | In-house | $10K |
| 23/02/17for Q2 2022 | In-house | $10K |